Elicio Therapeutics (ELTX) Financials: Revenue & Earnings
ELTX$1.79-0.04 -2.19%
$34.13M
Market Cap
—
P/E
—
Forward P/E
—
Score
Elicio Therapeutics (ELTX) Financials: Revenue & Earnings
ELTX price $1.79 -0.04 -2.19%
- Ticker
- ELTX
- Price
- $1.79
- Change
- -0.04 -2.19%
- Market cap ?
- $34.13M
- Beta ?
- 1.98
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
ELTX fair value $2,021.48. Price $1.79. Price is 100% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 8.07M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 2.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 19.07M. Net debt -4.05M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-12 | — | -0.44 | — | — |
| 2026-08-13 | -0.43 | -0.54 | — | — |
| 2026-05-11 | -0.65 | -0.49 | — | — |
| 2026-03-12 | -0.49 | -0.47 | — | — |
| 2025-11-13 | -0.60 | -0.62 | — | — |
| 2025-08-07 | -0.66 | -0.69 | — | — |
| 2025-05-13 | -0.87 | -0.67 | — | — |
| 2025-03-31 | -1.02 | -0.94 | — | — |
| 2024-11-13 | -1.39 | -0.73 | — | — |
| 2024-08-13 | -0.64 | -0.96 | — | — |
| 2024-05-15 | -1.15 | -1.09 | — | — |
| 2024-03-29 | -3.77 | -0.79 | — | — |
| 2023-11-09 | -1.27 | -0.80 | — | — |
| 2023-08-11 | -2.61 | -5.70 | — | 800.00K |
| 2023-05-10 | -2.51 | -5.40 | — | 800.00K |
| 2023-03-17 | -0.21 | -2.10 | — | 800.00K |
| 2022-11-14 | -3.00 | -3.20 | — | 625.00K |
| 2022-08-15 | -3.00 | -4.63 | 653.00K | 1.35M |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-31 | ADAMS JULIAN | Buy | 21.75K | $2.70 | 58.73K |
| 2026-08-31 | Ashe Carol Gail | Buy | 21.75K | $2.70 | 58.73K |
| 2026-08-31 | Chudnovsky Yekaterina | Buy | 21.75K | $2.70 | 58.73K |
| 2026-08-31 | Nissenson Allen | Buy | 21.75K | $2.70 | 58.73K |
| 2026-08-31 | RUFFOLO ROBERT R | Buy | 21.75K | $2.70 | 58.73K |
| 2026-08-31 | WILSON KAREN J | Buy | 21.75K | $2.70 | 58.73K |
| 2026-08-31 | Venkatesan Jay | Buy | 21.75K | $2.70 | 58.73K |
| 2026-07-16 | Haqq Christopher | Buy | 64.64K | $3.20 | 206.86K |
| 2026-07-16 | DeMuth Peter | Buy | 52.83K | $3.20 | 169.06K |
| 2026-07-16 | Shah Preetam | Buy | 60.83K | $3.20 | 194.67K |
| 2026-07-16 | Connelly Robert | Buy | 186.94K | $3.20 | 598.22K |
| 2026-02-02 | Connelly Robert | Buy | 147.20K | $8.10 | 1.19M |
| 2026-02-02 | Connelly Robert | Buy | 73.60K | — | — |
| 2026-02-02 | Shah Preetam | Buy | 47.90K | $8.10 | 387.99K |
| 2026-02-02 | Shah Preetam | Buy | 24.00K | — | — |
| 2026-02-02 | DeMuth Peter | Buy | 41.60K | $8.10 | 336.96K |
| 2026-02-02 | DeMuth Peter | Buy | 20.80K | — | — |
| 2026-02-02 | Haqq Christopher | Buy | 25.40K | — | — |
| 2026-02-02 | Haqq Christopher | Buy | 50.90K | $8.10 | 412.29K |
| 2025-12-09 | DeMuth Peter | Buy | 362 | $4.41 | 1.60K |
| 2025-12-09 | DeMuth Peter | Sell | 362 | $4.41 | 1.60K |
| 2025-06-03 | Chudnovsky Yekaterina | Buy | 103.22K | $7.75 | 799.99K |
| 2025-05-19 | Ashe Carol Gail | Buy | 7.90K | $5.84 | 46.14K |
| 2025-05-19 | Nissenson Allen | Buy | 7.90K | $5.84 | 46.14K |
| 2025-05-19 | Venkatesan Jay | Buy | 7.90K | $5.84 | 46.14K |
| 2025-05-19 | ADAMS JULIAN | Buy | 7.90K | $5.84 | 46.14K |
| 2025-05-19 | WILSON KAREN J | Buy | 7.90K | $5.84 | 46.14K |
| 2025-05-19 | RUFFOLO ROBERT R | Buy | 7.90K | $5.84 | 46.14K |
| 2025-05-19 | Chudnovsky Yekaterina | Buy | 7.90K | $5.84 | 46.14K |
| 2025-04-15 | Shah Preetam | Buy | 191.62K | $4.98 | 954.29K |
| 2025-03-24 | Shah Preetam | Other | 0 | — | — |
| 2025-03-05 | Chudnovsky Yekaterina | Buy | 3.50M | $5.81 | 20.34M |
| 2025-03-05 | Chudnovsky Yekaterina | Sell | 3.44M | $5.81 | 20.00M |
| 2025-02-03 | DeMuth Peter | Buy | 44.40K | $8.92 | 396.05K |
| 2025-02-03 | Haqq Christopher | Buy | 44.00K | $8.92 | 392.48K |
| 2025-02-03 | Connelly Robert | Buy | 121.60K | $8.92 | 1.08M |
| 2024-12-16 | DeMuth Peter | Buy | 381 | $4.41 | 1.68K |
| 2024-12-16 | DeMuth Peter | Sell | 381 | $4.41 | 1.68K |
| 2024-11-26 | Venkatesan Jay | Buy | 50.00K | $0.01 | 500 |
| 2024-11-26 | Venkatesan Jay | Sell | 50.00K | $0.01 | 500 |
| 2024-11-21 | WILSON KAREN J | Buy | 4.10K | $5.12 | 20.99K |
| 2024-11-21 | ADAMS JULIAN | Buy | 4.10K | $5.12 | 20.99K |
| 2024-11-21 | Ashe Carol Gail | Buy | 4.10K | $5.12 | 20.99K |
| 2024-11-21 | Venkatesan Jay | Buy | 4.10K | $5.12 | 20.99K |
| 2024-11-21 | RUFFOLO ROBERT R | Buy | 4.10K | $5.12 | 20.99K |
| 2024-11-21 | Chudnovsky Yekaterina | Buy | 4.10K | $5.12 | 20.99K |
| 2024-11-21 | Nissenson Allen | Buy | 4.10K | $5.12 | 20.99K |
| 2024-09-30 | Connelly Robert | Buy | 91.60K | $5.03 | 460.75K |
| 2024-09-30 | DeMuth Peter | Buy | 29.80K | $5.03 | 149.89K |
| 2024-09-30 | Haqq Christopher | Buy | 28.20K | $5.03 | 141.85K |
| 2024-08-12 | Chudnovsky Yekaterina | Buy | 3.44M | $5.81 | 20.00M |
| 2024-06-28 | Venkatesan Jay | Buy | 50.00K | $5.00 | 250.00K |
| 2024-06-28 | Venkatesan Jay | Buy | 50.00K | $0.01 | 500 |
| 2024-06-28 | Chudnovsky Yekaterina | Buy | 1.60M | $5.00 | 8.00M |
| 2024-06-28 | Chudnovsky Yekaterina | Buy | 1.60M | $0.01 | 16.00K |
| 2024-03-19 | Chudnovsky Yekaterina | Buy | 1.03M | $0.01 | 10.33K |
| 2024-02-01 | Piekos Brian | Buy | 43.23K | $4.50 | 194.51K |
| 2024-02-01 | Connelly Robert | Buy | 225.14K | $4.50 | 1.01M |
| 2024-02-01 | Haqq Christopher | Buy | 28.20K | $4.50 | 126.90K |
| 2024-02-01 | DeMuth Peter | Buy | 29.80K | $4.50 | 134.10K |
| 2024-02-01 | DeMuth Peter | Buy | 342 | $4.50 | 1.54K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 67, holders +14 vs prior quarter. Ownership 20.55%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| KNOLL CAPITAL MANAGEMENT, LLC | 1.21M | 581.04K | +92.10% | 4.74M |
| BLACKROCK, INC. | 766.00K | 715.41K | +1413.93% | 3.00M |
| VANGUARD CAPITAL MANAGEMENT LLC | 572.15K | 53.51K | +10.32% | 2.24M |
| CAPTION MANAGEMENT, LLC | 418.10K | 418.10K | New | 1.63M |
| GEODE CAPITAL MANAGEMENT, LLC | 311.35K | 176.19K | +130.35% | 1.22M |
| TORONTO DOMINION BANK | 200.00K | 200.00K | New | 782.00K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 181.40K | 136.30K | +302.22% | 709.27K |
| STATE STREET CORP | 179.42K | 128.80K | +254.44% | 701.53K |
| CAPTION MANAGEMENT, LLC | 165.70K | 165.70K | New | 647.89K |
| JANE STREET GROUP, LLC | 153.60K | 140.00K | +1029.41% | 600.58K |
| CITADEL ADVISORS LLC | 134.20K | 118.22K | +739.90% | 524.72K |
| NORTHERN TRUST CORP | 130.16K | 70.43K | +117.90% | 508.93K |
| DIADEMA PARTNERS LP | 112.10K | 112.10K | New | 438.31K |
| IKARIAN CAPITAL, LLC | 107.10K | 107.10K | New | 418.76K |
| IKARIAN CAPITAL, LLC | 100.00K | 100.00K | New | 391.00K |
| DIADEMA PARTNERS LP | 100.00K | 100.00K | New | 391.00K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 90.10K | 45.00K | +99.78% | 352.29K |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 88.91K | 88.91K | New | 347.62K |
| VANGUARD FIDUCIARY TRUST CO | 88.06K | 18.87K | +27.28% | 344.32K |
| ALLIANCEBERNSTEIN L.P. | 81.28K | 81.28K | New | 317.81K |
| UBS GROUP AG | 40.42K | 6.65K | +19.69% | 158.04K |
| JANE STREET GROUP, LLC | 32.40K | 18.80K | +138.24% | 126.68K |
| BOOTHBAY FUND MANAGEMENT, LLC | 32.40K | 32.40K | New | 126.68K |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 31.71K | 31.71K | New | 123.97K |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31.71K | 31.71K | New | 123.97K |
Earnings and financials
Elicio Therapeutics, Inc. (ELTX) trades at $1.79, with a market cap of $34.13M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn